NDC 71335-1253

Fexmid

Cyclobenzaprine Hydrochloride

Fexmid is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Cyclobenzaprine Hydrochloride.

Product ID71335-1253_b4aad312-9e2f-48ed-a9ae-2e7544d514a6
NDC71335-1253
Product TypeHuman Prescription Drug
Proprietary NameFexmid
Generic NameCyclobenzaprine Hydrochloride
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2018-04-30
Marketing CategoryANDA / ANDA
Application NumberANDA071611
Labeler NameBryant Ranch Prepack
Substance NameCYCLOBENZAPRINE HYDROCHLORIDE
Active Ingredient Strength8 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 71335-1253-0

10 TABLET, FILM COATED in 1 BOTTLE (71335-1253-0)
Marketing Start Date2018-04-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-1253-0 [71335125300]

Fexmid TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA071611
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-30

NDC 71335-1253-7 [71335125307]

Fexmid TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA071611
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-30

NDC 71335-1253-4 [71335125304]

Fexmid TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA071611
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-30

NDC 71335-1253-6 [71335125306]

Fexmid TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA071611
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-30

NDC 71335-1253-1 [71335125301]

Fexmid TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA071611
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-30

NDC 71335-1253-8 [71335125308]

Fexmid TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA071611
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-30

NDC 71335-1253-3 [71335125303]

Fexmid TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA071611
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-30

NDC 71335-1253-5 [71335125305]

Fexmid TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA071611
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-30

NDC 71335-1253-2 [71335125302]

Fexmid TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA071611
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-30

NDC 71335-1253-9 [71335125309]

Fexmid TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA071611
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-30

Drug Details

Active Ingredients

IngredientStrength
CYCLOBENZAPRINE HYDROCHLORIDE7.5 mg/1

OpenFDA Data

SPL SET ID:73dd66a1-2f55-4395-9705-1d9877618005
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 828299
  • 828301

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]
    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]

    NDC Crossover Matching brand name "Fexmid" or generic name "Cyclobenzaprine Hydrochloride"

    NDCBrand NameGeneric Name
    70199-014FexmidFexmid
    71205-059FexmidFexmid
    21695-830FexmidFexmid
    50436-0950FexmidFexmid
    53149-4851FexmidFexmid
    53149-4850FexmidFexmid
    55700-726FexmidFexmid
    63629-7803FexmidFexmid
    71335-1253FexmidFexmid
    0093-1920Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0093-1921Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0093-3420Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0093-3421Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0093-3422Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0115-1436Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0115-1437Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0179-0057cyclobenzaprine hydrochloridecyclobenzaprine hydrochloride
    0179-0189cyclobenzaprine hydrochloridecyclobenzaprine hydrochloride
    0378-0751Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
    0378-0761Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
    0378-0771Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
    0440-1350Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0440-7350Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0591-3256Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0591-3330Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0591-5658Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0615-3520Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
    0615-7528Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
    0615-8182Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0904-7809Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride

    Trademark Results [Fexmid]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    FEXMID
    FEXMID
    78957905 3327963 Live/Registered
    CASPER PHARMA LLC
    2006-08-22
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.